文献速递妇科

长期维生素D治疗可缩小人子宫肌瘤异种移植动物模型中的肌瘤体积

Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model.
PubMed 文献 · Fertil Steril · 2019-11-15

该临床前研究将人子宫肌瘤组织植入去卵巢NOD-SCID小鼠,分别给予维生素D 0.5或1 μg/kg/d或溶媒处理21天或60天。短期治疗未见肌瘤体积改变,长期高剂量维生素D显著缩小肌瘤体积并抑制增殖、减少纤维化、促进凋亡。作者认为长期维生素D可作为安全、非手术的缩小肌瘤治疗选择且无副作用。

要点

  • 短期维生素D治疗未见改变人子宫肌瘤异种移植瘤体积。
  • 长期高剂量维生素D(1 μg/kg/d)显著缩小肌瘤体积并抑制细胞增殖。
  • 长期高剂量维生素D显著降低胶原I、PAI-1和TGF-β3表达并增加凋亡。

核心结论

  • 长期维生素D作为抗增殖、抗纤维化和促凋亡治疗,为缩小子宫肌瘤提供安全、非手术且无副作用的选择。

研究设计与样本

  • 临床前研究,将人子宫肌瘤组织植入去卵巢NOD-SCID小鼠。
  • 小鼠接受维生素D 0.5 μg/kg/d或1 μg/kg/d或溶媒处理21天或60天。

主要发现

  • 短期维生素D治疗基于在体监测和肉眼检查未显示改变肌瘤体积。
  • 长期高剂量维生素D处理诱导肌瘤体积显著缩小。
  • 短期治疗未降低细胞增殖,而长期1 μg/kg/d维生素D较对照显著降低增殖。
  • 短期治疗未改变胶原I和纤溶酶原激活物抑制剂1,长期高剂量维生素D使两者均显著降低。
  • 长期高剂量维生素D显著降低TGF-β3表达;短期和长期高剂量维生素D均显著增加凋亡。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the effects of short- and long-term vitamin D treatment on uterine leiomyomas in vivo through cell proliferation, extracellular matrix (ECM) degradation, and apoptosis. DESIGN: Preclinical study of human leiomyoma treatment with vitamin D in an nonhuman animal model. SETTING: Hospital and university laboratories. PATIENT(S)/ANIMAL(S): Human leiomyomas were collected from patients and implanted in ovariectomized NOD-SCID mice. INTERVENTION(S): Mice were treated with vitamin D (0.5 μg/kg/d or 1 μg/kg/d) or vehicle for 21 or 60 days. MAIN OUTCOME MEASURE(S): Vitamin D effect in xenograft tissue was assessed by monitoring tumor size (18F-FDG positron-emission tomography/computerized tomography and macroscopic examination), cell proliferation (immunohistochemistry and quantitative real-time polymerase chain reaction [qRT-PCR]), ECM (Western blot), transforming growth factor (TGF) β3 (qRT-PCR), and apoptosis (Westrn blot and TUNEL). RESULT(S): Short-term treatment with vitamin D did not appear to alter leiomyoma size, based on in vivo monitoring and macroscopic examination. However, long-term high-dose treatment induced a significant reduction in leiomyoma size. Cell proliferation was not decreased in the short term, whereas 1 μg/kg/d vitamin D in the long term significantly reduced proliferation compared with control. Although collagen-I and plasminogen activator inhibitor 1 were not modified by short-term treatment, they were both significantly reduced by long-term high-dose vitamin D. Similarly, long-term high-dose vitamin D significantly reduced TGF-β3 expression. Finally, apoptosis significantly increased with both short- and long-term high-dose vitamin D treatment. CONCLUSION(S): Long-term vitamin D acts as an antiproliferative, antifibrotic, and proapoptotic therapy that provides a safe, nonsurgical therapeutic option for reducing uterine leiomyoma size without side-effects.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Corachán A, Ferrero H, Escrig J, et al. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil Steril. 2019. PMID: 31739978. doi:10.1016/j.fertnstert.2019.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。